Serine/threonine-protein phosphatase PP1-gamma catalytic subunit
Cross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Serine/threonine-protein phosphatase PP1-gamma catalytic subunit as ChEMBL target CHEMBL4438, mapped to UniProt P36873. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Why Serine/threonine-protein phosphatase PP1-gamma catalytic subunit matters
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit is reviewed as Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (UniProt P36873); the current evidence base includes 1 approved drug, 32 compounds, and 34 assays, with lead potency reaching pChEMBL 11.0.
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit Sequence length is 323 aa.
Review this target as Serine/threonine-protein phosphatase PP1-gamma catalytic subunit, mapped to UniProt P36873. Sequence length is 323 aa.
Protein source · UniProt accession via ChEMBL component mappingDisease relevance is not yet populated for this evidence card.
This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
ChEMBL target recordChEMBL currently tracks 1 approved drug, 32 compounds, and 34 assays for this target. The dominant activity type is IC50. CHEMBL444092 is the current potency anchor at pChEMBL 11.0.
Use CHEMBL444092 as the tractability anchor when discussing potency (pChEMBL 11.0).
Activity source · ChEMBL 36 via Core EngineStart with the right source
Pick the first block or linked source that matches the review question in front of you.
Start with the review rationale when you need to explain why Serine/threonine-protein phosphatase PP1-gamma catalytic subunit matters before drilling into raw source blocks.
Jump to Review RationaleGo back to the target snapshot when you need the naming and mapping contract behind UniProt P36873, not just the summarized rationale.
Open Protein ContextUse the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.
Open Disease ContextSnapshot State
No project snapshot selected. Export uses the live evidence card state.
pChEMBL Activity Distribution
Top 5 Inhibitors (by pChEMBL)
| Structure | Compound | pChEMBL | Type | Phase |
|---|---|---|---|---|
|
|
No preferred name
CHEMBL444092
|
11.0 | IC50 | — |
|
|
No preferred name
CHEMBL430266
|
9.8 | IC50 | — |
|
|
No preferred name
CHEMBL1366322
|
8.8 | IC50 | — |
|
|
No preferred name
CHEMBL408120
|
8.5 | Ki | — |
|
|
No preferred name
CHEMBL406220
|
8.3 | Ki | — |